Singer Capital Markets appointed as Joint Broker to Yourgene Health plc
The Board of Yourgene Health plc is pleased to announce that it has appointed Singer Capital Markets as Joint Broker to the Company with immediate effect.
About Yourgene Health plc
Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services. The group works in partnership with global leaders in DNA technology to advance diagnostic science.
Yourgene develops and commercialises simple and accurate molecular diagnostic solutions, for reproductive health and molecular genetics. The Group’s products include non-invasive prenatal tests (NIPT) for Down’s Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, male infertility tests and genetic disease tests. Yourgene’s commercial footprint is already established in the UK, Europe, the Middle East, Africa and Asia.
Market Cap: £113.94 million*
Website: Click here
*As at 29/07/2020